Pluri Inc. Customer Advances, Current
Pluri Inc. (PLUR) had Customer Advances, Current of $43.00 thousand as of 2024-06-30, per its 10-K filed 2024-09-18.
Discontinued › Notes › Revenue Recognition and Deferred Revenue
us-gaap:CustomerAdvancesCurrent · last filed 2024-09-18
- 2024-06-30: Customer Advances, Current $43.00K.
- 2024-03-31: Customer Advances, Current $101.00K.
- 2023-06-30: Customer Advances, Current $7.00K.
- 2015-09-30: Customer Advances, Current $70.00K.
| Period end | Customer Advances, Current |
|---|---|
| 2024-06-30 | $43.00K 10-K · filed 2024-09-18 |
| 2024-03-31 | $101.00K 10-Q · filed 2024-05-09 |
| 2023-06-30 | $7.00K 10-K · filed 2024-09-18 |
| 2015-09-30 | $70.00K 10-Q · filed 2015-11-05 |
| 2015-06-30 | $93.00K 10-K · filed 2016-09-07 |
| 2015-03-31 | $124.00K 10-Q · filed 2015-05-06 |
| 2014-12-31 | $143.00K 10-Q · filed 2015-02-05 |
| 2014-09-30 | $218.00K 10-Q · filed 2014-11-06 |
| 2014-06-30 | $247.00K 10-K · filed 2015-09-09 |
| 2014-03-31 | $261.00K 10-Q · filed 2014-05-08 |
| 2013-12-31 | $297.00K 10-Q · filed 2014-02-05 |
| 2013-09-30 | $356.00K 10-Q · filed 2013-11-05 |
| 2013-06-30 | $393.00K 10-K · filed 2014-09-11 |
| 2013-03-31 | $567.00K 10-Q · filed 2013-05-08 |
| 2012-12-31 | $599.00 10-Q · filed 2013-01-31 |
| 2012-09-30 | $959.00K 10-Q · filed 2012-11-06 |
| 2012-06-30 | $1.58M 10-K · filed 2013-09-11 |
| 2012-03-31 | $1.51M 10-Q · filed 2012-05-08 |
| 2011-12-31 | $1.93M 10-Q · filed 2012-02-09 |
| 2011-09-30 | $2.00M 10-Q · filed 2011-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |